Citation Impact
Citing Papers
VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia
2003 Standout
Structure of a type III secretion needle at 7-Å resolution provides insights into its assembly and signaling mechanisms
2012
Autonomic Nerve Development Contributes to Prostate Cancer Progression
2013 StandoutScience
Mutational Analysis of the Flagellar Rotor Protein FliN: Identification of Surfaces Important for Flagellar Assembly and Switching
2006
Political Constraints on Contractual Redistribution
1974 StandoutNobel
Pharmacologic Targeting of Hypoxia-Inducible Factors
2019 StandoutNobel
UV Light Potentiates STING (Stimulator of Interferon Genes)-dependent Innate Immune Signaling through Deregulation of ULK1 (Unc51-like Kinase 1)
2015 StandoutNobel
Re-epithelialization and immune cell behaviour in an ex vivo human skin model
2020 Standout
Prostate Stroma: Physiology
1999
Multicopy plasmid modification with phage λ Red recombineering
2007
Deciphering the assembly of the Yersinia type III secretion injectisome
2010
Q39, a quinoxaline 1,4-Di-N-oxide derivative, inhibits hypoxia-inducible factor-1α expression and the Akt/mTOR/4E-BP1 signaling pathway in human hepatoma cells
2010
HIF-1α, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas
2005 StandoutNobel
A flagellum-specific chaperone facilitates assembly of the core type III export apparatus of the bacterial flagellum
2017 StandoutNobel
Atomic model of the type III secretion system needle
2012 StandoutNatureNobel
Adenovirus-mediated FLT1-targeted proapoptotic gene therapy of human prostate cancer
2004
Role and activation of type III secretion system genes in Pseudomonas aeruginosa-induced Drosophila killing
2002
Bioinformatics analysis of the locus for enterocyte effacement provides novel insights into type-III secretion
2005
Thrombospondin‐1, vascular endothelial growth factor expression and their relationship with p53 status in prostate cancer and benign prostatic hyperplasia
2002
The type III needle and the damage done
2005
Activation and regulation of the inflammasomes
2013 Standout
High-resolution structure of the Shigella type-III secretion needle by solid-state NMR and cryo-electron microscopy
2014 StandoutNobel
Blockade of NF-κB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis
2001
Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy
2001 Standout
Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways
2005 StandoutNobel
Angiogenesis in cancer and other diseases
2000 StandoutNature
The biology of VEGF and its receptors
2003 Standout
Molecular Insights into the Biosynthesis of Guadinomine: A Type III Secretion System Inhibitor
2012 StandoutNobel
Macrophage Activation Redirects Yersinia-Infected Host Cell Death from Apoptosis to Caspase-1-Dependent Pyroptosis
2007
Angiogenesis in health and disease
2003 Standout
Assembly of the bacterial type III secretion machinery
2014
Thermal ablation of tumours: biological mechanisms and advances in therapy
2014 Standout
Interactions between C ring proteins and export apparatus components: a possible mechanism for facilitating type III protein export
2006
The Needle Component of the Type III Secreton of Shigella Regulates the Activity of the Secretion Apparatus
2005
The type III secretion injectisome
2006
The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis
2009 Standout
New structural insights into the bacterial type III secretion system
2006
The NLRP12 Inflammasome Recognizes Yersinia pestis
2012
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
2017 Standout
Molecular regulation of vessel maturation
2003 Standout
VEGF-targeted therapy: mechanisms of anti-tumour activity
2008 Standout
Pyroptosis: host cell death and inflammation
2009 Standout
Basic and Therapeutic Aspects of Angiogenesis
2011 Standout
Tumor metastasis: mechanistic insights and clinical challenges
2006 Standout
Overproduction of VEGF165 Concomitantly Expressed with its Receptors Promotes Growth and Survival of Melanoma Cells through MAPK and PI3K Signaling
2004
Immunologic and genetic considerations of cutaneous lupus erythematosus: A comprehensive review
2013
Hypoxia-inducible Factor-1 Deficiency Results in Dysregulated Erythropoiesis Signaling and Iron Homeostasis in Mouse Development
2006 StandoutNobel
Protein delivery into eukaryotic cells by type III secretion machines
2006 Nature
The anti-angiogenic basis of metronomic chemotherapy
2004 Standout
Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
2006 Standout
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
A conserved structural motif mediates formation of the periplasmic rings in the type III secretion system
2009 StandoutNobel
Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal
1999
Cryo-EM structure of a type IV secretion system
2022 StandoutNatureNobel
Tumor Angiogenesis
2008 Standout
FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy?
2008
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
The cryobiology of cryosurgical injury
2002
Tumorigenesis and the angiogenic switch
2003 Standout
Prediction of the structure of symmetrical protein assemblies
2007 StandoutNobel
Molecular model of a type III secretion system needle: Implications for host-cell sensing
2006
The Von Hippel-Lindau Tumor Suppressor Gene and Kidney Cancer
2004 StandoutNobel
Type III secretion: a bacterial device for close combat with cells of their eukaryotic host
2000
Antiangiogenic and Antitumor Effects of Bevacizumab in Patients With Inflammatory and Locally Advanced Breast Cancer
2006
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
2004 Standout
ANARCHY, UNCERTAINTY, AND THE EMERGENCE OF PROPERTY RIGHTS
1993
Molecular Basis of Bacterial Outer Membrane Permeability Revisited
2003 Standout
Neuropilin 1 deficiency on CD4+Foxp3+ regulatory T cells impairs mouse melanoma growth
2012 StandoutNobel
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGF
1999 StandoutScience
The hypoxia-inducible genes VEGF and CA9 are differentially regulated in superficial vs invasive bladder cancer
2002 StandoutNobel
MicroRNA-200b Regulates Vascular Endothelial Growth Factor–Mediated Alterations in Diabetic Retinopathy
2011
Process of Protein Transport by the Type III Secretion System
2004
Political Uncertainty and Corporate Investment Cycles
2012 Standout
Vascular endothelial growth factor selectively targets boronated dendrimers to tumor vasculature
2005
The Host Defense of Drosophila melanogaster
2007 StandoutNobel
What's the point of the type III secretion system needle?
2008
The von Hippel-Lindau Tumor Suppressor Protein and Clear Cell Renal Carcinoma
2007 StandoutNobel
Some implications of anarchy for the distribution of property
1974
Assembly and Function of Type III Secretory Systems
2000
Angiogenesis in urological malignancy: prognostic indicator and therapeutic target
1999
Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme
2007 Standout
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Structure and Electrophysiological Properties of the YscC Secretin from the Type III Secretion System of Yersinia enterocolitica
2004
Type III secretion systems and bacterial flagella: Insights into their function from structural similarities
2003
Language and Agency
2001 Standout
Osteopontin and MMP9: Associations with VEGF Expression/Secretion and Angiogenesis in PC3 Prostate Cancer Cells
2013
Mechanisms of Endocytosis
2009 Standout
Control of effector export by the Pseudomonas aeruginosa type III secretion proteins PcrG and PcrV
2010
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
2004 Standout
Works of Michael Jackson being referenced
Three-dimensional Structure of a Macromolecular Assembly that Regulates Type III Secretion in Yersinia pestis
2004
Interactions between type III secretion apparatus components fromYersinia pestisdetected using the yeast two-hybrid system
2000
Exposure and binding of selected immunodominant La/SSB epitopes on human apoptotic cells
2005
DsbA Is Required for Stable Expression of Outer Membrane Protein YscC and for Efficient Yop Secretion inYersinia pestis
1999
A potential autocrine role for vascular endothelial growth factor in prostate cancer.
2002
The Yersinia pestis type III secretion needle plays a role in the regulation of Yop secretion
2005
Personhood and Agency: The Experience of Self and Other in African Cultures
1995
Calcium-Regulated Type III Secretion of Yop Proteins by an Escherichia coli hha Mutant Carrying a Yersinia pestis pCD1 Virulence Plasmid
2006
Explorations in the Theory of Anarchy
1974
Membrane localization and topology of the Yersinia pestis YscJ lipoprotein
2008
YscB of Yersinia pestis Functions as a Specific Chaperone for YopN
1998
Vascular Endothelial Growth Factor (VEGF) Expression in Prostate Cancer and Benign Prostatic Hyperplasia
1997